| Package | us.nlm.vsac |
| Type | ValueSet |
| Id | Id |
| FHIR Version | R4 |
| Source | http://fhir.org/packages/us.nlm.vsac/https://vsac.nlm.nih.gov/valueset/2.16.840.1.113883.3.464.1003.110.12.1044/expansion |
| Url | http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044 |
| Version | 20170504 |
| Status | active |
| Date | 2022-03-07T11:14:02-05:00 |
| Name | ChildInfluenzaVaccineAdministered |
| Title | Child Influenza Vaccine Administered |
| Experimental | False |
| Realm | us |
| Authority | hl7 |
| Purpose | (Clinical Focus: The purpose of this value set is to represent concepts for an influenza vaccination for use in children 2 and younger.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent an influenza vaccination for use in children 2 and younger.),(Exclusion Criteria: Excludes influenza vaccines not recommended for use in children 2 and younger.) |
No resources found
| CodeSystem | |
http://snomed.info/sct  | SNOMED CT (all versions) |
| http://www.ama-assn.org/go/cpt | Current Procedural Terminology (CPT®) |
| http://snomed.info/sct | Nutrition Care Process Terminology module |
| http://snomed.info/sct | veri |
| http://www.ama-assn.org/go/cpt | Current Procedural Terminology (CPT®) |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115 | Child Influenza Vaccine Administered |
| http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116 | Child Influenza Vaccine Administered |
FHIR{
"resourceType" : "ValueSet",
"id" : "2.16.840.1.113883.3.464.1003.110.12.1044",
"meta" : {
"versionId" : "20",
"lastUpdated" : "2023-12-21T17:43:03.000-05:00",
"profile" : [
"http://hl7.org/fhir/StructureDefinition/shareablevalueset",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
"http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
]
},
"extension" : [
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
"valueContactDetail" : {
"name" : "NCQA PHEMUR Author"
}
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
"valueDate" : "2024-02-13"
},
{
"url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
"valueDate" : "2017-05-04"
}
],
"url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.12.1044",
"identifier" : [
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.3.464.1003.110.12.1044"
}
],
"version" : "20170504",
"name" : "ChildInfluenzaVaccineAdministered",
"title" : "Child Influenza Vaccine Administered",
"status" : "active",
"experimental" : false,
"date" : "2022-03-07T11:14:02-05:00",
"publisher" : "NCQA PHEMUR",
"jurisdiction" : [
{
"coding" : [
{
"system" : "urn:iso:std:iso:3166",
"code" : "US"
}
]
}
],
"purpose" : "(Clinical Focus: The purpose of this value set is to represent concepts for an influenza vaccination for use in children 2 and younger.),(Data Element Scope: This value set may use a model element related to Procedure.),(Inclusion Criteria: Includes concepts that represent an influenza vaccination for use in children 2 and younger.),(Exclusion Criteria: Excludes influenza vaccines not recommended for use in children 2 and younger.)",
"compose" : {
"include" : [
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1116"
]
},
{
"valueSet" : [
"http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.464.1003.110.11.1115"
]
}
]
},
"expansion" : {
"identifier" : "urn:uuid:b254a6bc-9cbf-4ae0-941b-c032ab260ed9",
"timestamp" : "2024-12-10T10:35:47-05:00",
"total" : 12,
"contains" : [
{
"system" : "http://snomed.info/sct",
"version" : "http://snomed.info/sct/731000124108/version/20240901",
"code" : "86198006",
"display" : "Administration of vaccine product containing only Influenza virus antigen (procedure)"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90655",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90657",
"display" : "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90661",
"display" : "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90673",
"display" : "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90674",
"display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90685",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90686",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90687",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90688",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90689",
"display" : "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
},
{
"system" : "http://www.ama-assn.org/go/cpt",
"version" : "2025",
"code" : "90756",
"display" : "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
}
]
},
"text" : {
}
}
XIG built as of ??metadata-date??. Found ??metadata-resources?? resources in ??metadata-packages?? packages.